{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-023805","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.020382+00:00","generated_at":"2026-05-22T04:32:44.441541+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"The Joint Corp. Q1 revenue up 7% to $13.1M; net loss widens to $506k; reiterates 2025 guidance","bullets":["Q1 revenue $13.1M (+7% YoY); system-wide sales $132.6M (+5%); comp sales 3%.","Net loss from continuing ops $506k ($0.03/share) vs $399k in Q1 2024; adjusted EBITDA from continuing ops $46k vs $425k.","Reiterated FY2025 guidance: system-wide sales $550-570M; consolidated adj. EBITDA $10-11.5M; new franchised clinics 30-40.","Sold 9 franchise licenses; opened 5 franchised clinics; total clinics 969 (847 franchised).","Transitioning to pure-play franchisor with digital marketing and pricing initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-023805","json":"https://secwatch.observer/filing/0001628280-25-023805.json","markdown":"https://secwatch.observer/filing/0001628280-25-023805.md","text":"https://secwatch.observer/filing/0001628280-25-023805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000162828025023805/0001628280-25-023805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000162828025023805/jynt-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T04:32:44.441541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}